Literature DB >> 1704095

The TraT lipoprotein as a vehicle for the transport of foreign antigenic determinants to the cell surface of Escherichia coli K12: structure-function relationships in the TraT protein.

I M Taylor1, J L Harrison, K N Timmis, C D O'Connor.   

Abstract

The TraT protein is a surface-exposed lipoprotein, specified by plasmids of the IncF group, that mediates serum resistance and surface exclusion. The structure and function of the TraT protein determined by plasmid R6-5 was probed by genetic insertion of a foreign antigenic determinant, the C3 epitope of polio virus, at residues 61, 125, 180, 200 or 216 of the protein. The chimaeric proteins were transported to the outer membrane and, in three cases, immunoassays with an anti-C3 monoclonal antibody indicated that the C3 epitope was exposed on the cell surface. Three of the hybrids, with insertions at residues 125, 180 and 200, assembled into the trypsin-resistant oligomeric form characteristic of the wild-type protein, which suggested that these regions are not involved in TraT subunit:subunit interactions. Additionally, the hybrid protein carrying the C3 epitope at position 180 functioned in a genetic suppression assay and retained partial surface-exclusion activity. Thus, its localization, folding and organization does not appear to be grossly altered from that of the wild-type protein. Applications of the protein for the transport of foreign antigenic determinants to the cell surface are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1704095     DOI: 10.1111/j.1365-2958.1990.tb00705.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  10 in total

1.  Conversion of citrate synthase into citryl-CoA lyase as a result of mutation of the active-site aspartic acid residue to glutamic acid.

Authors:  W J Man; Y Li; C D O'Connor; D C Wilton
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

2.  Genetic insertion and exposure of a reporter epitope in the ferrichrome-iron receptor of Escherichia coli K-12.

Authors:  G S Moeck; B S Bazzaz; M F Gras; T S Ravi; M J Ratcliffe; J W Coulton
Journal:  J Bacteriol       Date:  1994-07       Impact factor: 3.490

3.  CS31A capsule-like antigen as an exposure vector for heterologous antigenic determinants.

Authors:  F Bousquet; C Martin; J P Girardeau; M C Méchin; M Der Vartanian; H Laude; M Contrepois
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

4.  Topology of the membrane protein LamB by epitope tagging and a comparison with the X-ray model.

Authors:  S M Newton; P E Klebba; V Michel; M Hofnung; A Charbit
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

5.  Outer membrane permeability of Escherichia coli K12: isolation, cloning and mapping of suppressors of a defined antibiotic-hypersensitive mutant.

Authors:  S Y Qi; S Sukupolvi; C D O'Connor
Journal:  Mol Gen Genet       Date:  1991-10

Review 6.  Colicin V virulence plasmids.

Authors:  V L Waters; J H Crosa
Journal:  Microbiol Rev       Date:  1991-09

7.  The effect of replacing the conserved active-site residues His-264, Asp-312 and Arg-314 on the binding and catalytic properties of Escherichia coli citrate synthase.

Authors:  W J Man; Y Li; C D O'Connor; D C Wilton
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

8.  The region around residue 115 of human bactericidal/permeability-increasing protein is not involved in lipopolysaccharide binding or bactericidal activity. Chemical synthesis and expression of a gene coding for the active domain and characterization of recombinant proteins.

Authors:  S Y Qi; Y Li; C D O'Connor
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

9.  Membrane topology of Borrelia burgdorferi and Treponema pallidum lipoproteins.

Authors:  J D Jones; K W Bourell; M V Norgard; J D Radolf
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

Review 10.  Targeting TLR2 for vaccine development.

Authors:  Afonso P Basto; Alexandre Leitão
Journal:  J Immunol Res       Date:  2014-06-26       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.